Target intelligence / Profile preview

Axonal regeneration support

Molecular classification
Other
01

Overview

Axonal regeneration support refers to the collection of cellular and molecular mechanisms that enable neurons to regrow axons following injury. Regeneration can occur naturally in the peripheral nervous system (PNS) but is limited in the central nervous system (CNS) due to both extrinsic inhibitory cues (such as glial scarring and myelin-associated inhibitors) and intrinsic constraints on the neurons’ growth capacity. Key molecular pathways that support regeneration include increased transcriptional activity (via factors like c-Jun, STAT3, ATF3, and Smad1), activation of growth-associated signaling cascades (such as JAK/STAT, PI3K/Akt/mTOR), epigenetic remodelling (notably histone acetylation), cytoskeletal reorganization, and enhanced local energy metabolism (glycolysis and mitochondrial transport). Therapeutic strategies aim to reactivate these mechanisms (e.g., via gene therapy, drugs, or biomaterial scaffolds) to promote repair following spinal cord or brain injury[1][2][3][4][5][6].

Other names
axonal regenerationaxon regrowthnerve repairneurite outgrowth
02

Mechanism of action

Pathway activation (e.g., increasing cAMP, JAK/STAT, MAPK, mTOR signaling[2][5][6]); Inhibition of growth inhibitors (e.g., Rho/ROCK pathway[2][5]); Modulation of cytoskeletal dynamics; Epigenetic enhancement (histone acetylation[2][5])

03

Biological functions

Cell growth and repairNeurite extensionCytoskeletal reorganizationResponse to injuryTranscriptional activationEpigenetic modulation
04

Disease associations

Neurodegenerative diseaseSpinal cord injuryPeripheral nerve injuryOther nervous system trauma
05

Safety considerations

Off-target effects of pathway modulation (e.g., enhanced cell growth may risk tumorigenesis)Potential hyperexcitability or maladaptive sproutingImmune/inflammatory complications after CNS injury
06

Interacting drugs

low-dose paclitaxel

1 more in the full profile.

07

Biomarkers

Expression levels of regeneration-associated genes (RAGs): GAP-43, Rab13, Coro1bActivity/phosphorylation of transcription factors: STAT3, c-Jun, ATF3, Smad1, p53PTEN and SOCS3 status in neurons

Beyond the preview

Go deeper on Axonal regeneration support.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Axonal regeneration support.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call